CBT

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 1 B955 M936 M923 M899 M849 M 3.61 B Gross profit 240 M235 M241 M244 M220 M211 M 916 M Operating expenses 103 M80 M79 M77 M94 M91 M 341 M Selling/general/admin expenses 73 M66 M64 M62 M68 M69 M 263 M Research & development 17 M14 M15 M15 M15 M13 M 58 M Operating income 150 M155 M162 M167 M137 M129 M 595 M Non-Operating Income, Total 4 M7 M8 M7 M-2 M7 M 20 M Interest expense, net of interest capitalized 19 M18 M19 M19 M20 M18 M 76 M Non-Operating Income, excl. Interest Expenses -12 M-12 M-12 M-12 M-13 M-12 M -49 M Unusual income/expense -3 M1 M1 M0-9 M1 M — Pretax income 136 M145 M154 M156 M117 M119 M 546 M Equity in earnings 1 M1 M3 M1 M2 M1 M 7 M Taxes -10 M41 M49 M43 M63 M37 M 192 M Non-controlling/minority interest 9 M11 M11 M12 M11 M9 M 43 M After tax other income/expense -3 M-37 M-15 M-8 M-9 M-10 M — Net income before discontinued operations 137 M93 M94 M101 M43 M73 M 311 M Discontinued operations —————— — Net income 137 M93 M94 M101 M43 M73 M 311 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 134 M92 M92 M100 M42 M72 M 306 M Basic earnings per share (Basic EPS) 2.451.691.711.870.81.38 5.76 Diluted earnings per share (Diluted EPS) 2.411.671.691.860.81.37 5.72 Average basic shares outstanding 55.1 M54.3 M54 M53.5 M53.7 M52.7 M 213.9 M Diluted shares outstanding 55.7 M55 M54.4 M53.8 M54.2 M52.9 M 215.3 M EBITDA 174 M192 M200 M206 M166 M161 M 733 M EBIT 137 M155 M162 M167 M126 M120 M 575 M Cost of revenue 761 M720 M695 M679 M679 M638 M 2.69 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 37 M37 M38 M39 M40 M41 M 158 M